Bill of Materials & Batch Composition Calculator – Tablets
📖 Continue Exploring
This page includes a comprehensive guide, a detailed FAQ section, and links to additional pharmaceutical calculators. Use the quick navigation below to jump directly to any section.
Bill of Materials & Batch Composition – Tablets – Guide
What is a Bill of Materials (BOM) in tablet manufacturing?
A Bill of Materials (BOM) is a comprehensive list of all raw materials required to manufacture a tablet batch. It includes every Active Pharmaceutical Ingredient (API), excipient, processing aid, coating material, and solvent (where applicable), together with their required quantities.
The BOM forms the basis for material procurement, dispensing, production planning, inventory management, and batch documentation. In pharmaceutical manufacturing, the BOM must accurately reflect the approved Master Formula Record (MFR) to ensure Good Manufacturing Practices (GMP) compliance and batch consistency.
Why is API assay correction necessary during pharmaceutical batch manufacturing?
APIs rarely assay exactly 100% on an as-is basis because they may contain moisture, residual solvents, or other volatile components. If assay correction is not applied, the finished tablets may contain less or more active ingredient than intended. Adjusting the API quantity according to the as-is assay ensures that every tablet contains the target label claim while maintaining compliance with pharmacopoeial specifications and regulatory requirements.
What is the difference between assay on an as-is basis, dried-basis, and anhydrous-basis?
As-is basis calculates potency including all moisture and volatiles, while dried-basis removes water/volatiles, and anhydrous-basis further excludes bound water of hydration. Pharmaceutical batch calculations should generally be based on the as-is assay. Using a dried or anhydrous assay directly without conversion can lead to incorrect API quantities and inaccurate finished product assay.
What are the three main tablet manufacturing methods, and how do they differ?
The three primary tablet manufacturing methods are Direct Compression (DC), Wet Granulation (WG), and Dry Granulation (DG).
🟦 Direct Compression (DC): Direct compression involves blending the API with directly compressible excipients and compressing the mixture without granulation, making it the simplest and most cost-effective process.
🟩 Wet Granulation (WG): Wet granulation uses a binder solution to form granules, improving powder flow, compressibility, and content uniformity, making it suitable for challenging formulations.
🟧 Dry Granulation (DG): Dry granulation compacts powders without liquid, typically by roller compaction or slugging, and is preferred for moisture- or heat-sensitive APIs.
Selection of the manufacturing method depends on:
- Physicochemical properties of the API
- Excipient characteristics
- Desired tablet quality attributes
Why are different formulation stages used in tablet manufacturing?
Tablet manufacturing is divided into distinct formulation and processing stages because no single operation can simultaneously achieve:
- Uniform drug distribution
- Excellent powder flow
- Adequate compressibility
- Optimal tablet hardness
- Efficient tablet ejection
- Consistent product quality
Each stage is specifically designed to develop or preserve critical material properties, ensuring that the finished tablets consistently meet predefined quality, safety, efficacy, and regulatory requirements under GMP.
📌 Strategic Function of Each Stage
🟦 Sifting (Screening)
API and/or excipients are passed through appropriately sized sieves to remove oversized particles, foreign matter, and lumps while achieving a consistent particle size distribution. Sifting enhances blend uniformity, improves powder flow, and contributes to reproducible manufacturing performance.
🟦 Intra-granular Mixing (Dry Mixing)
The API is blended with selected excipients before granulation. This step promotes uniform drug distribution throughout the formulation, minimizes content variability, and ensures dose uniformity before the binder is introduced.
🟦 Binder Preparation & Granulation
A binder solution or paste is added to the powder blend to agglomerate fine particles into larger, denser granules. Granulation improves powder flow, compressibility, bulk density, and reduces segregation during downstream processing, thereby enhancing manufacturing consistency.
🟦 Drying
The wet granules are dried to reduce residual moisture to the target level. Proper drying improves granule stability, prevents microbial growth, minimizes sticking during compression, and ensures consistent flow and compressibility. Over-drying or under-drying can adversely affect granule quality and final tablet performance.
🟦 Milling & Sifting (Screening)
The dried granules are passed through a mill to break down oversized agglomerates and are passed through appropriately sized sieves to remove oversized granules and lumps. Uniform granule size improves blend homogeneity, die filling, compressibility, and tablet weight uniformity.
🟦 Extra-granular Blending
After drying and milling, the granules are blended with extra-granular excipients such as disintegrants, fillers, glidants, or other ingredients that are intentionally added after granulation to optimize tablet performance and processing characteristics.
🟦 Lubrication
Lubricants, typically magnesium stearate or similar materials, are added immediately before compression to reduce friction between the granules, punches, and die walls. This facilitates smooth tablet ejection, minimizes tooling wear, and prevents sticking and picking. Since excessive lubrication can adversely affect tablet hardness, disintegration, and dissolution, this stage requires careful control of both mixing time and lubricant concentration.
🟦 Compression
The lubricated blend is compressed into tablets using a tablet press under controlled compression force, machine (turret) speed, force-feeder speed etc. This stage determines several critical quality attributes, including tablet weight, hardness, thickness, friability, content uniformity, and mechanical integrity. Proper compression parameters are essential to ensure consistent tablet quality and robust manufacturing performance.
🟦 Coating
When required, compressed tablets are film- or enteric-coated with appropriate coating materials. Coating may improve product appearance, mask unpleasant taste or odor, protect the API from moisture, oxygen, or light, enhance swallowability, improve product identification, or provide modified-release characteristics such as delayed or sustained drug release.
🟦 Visual Inspection
Following compression or coating, tablets undergo visual inspection to identify and remove defective units before packaging. Inspection helps detect defects such as chipped or broken tablets, capping, lamination, cracking, sticking, mottling, colour variation, coating defects, embossing defects, contamination, and other visible abnormalities. This stage provides an additional quality assurance checkpoint to ensure only conforming tablets proceed to packaging and distribution.
Why are water and processing solvents not included in the final tablet composition?
Purified water and many processing solvents are used only to facilitate granulation or coating and are intentionally removed during drying. Since these materials do not remain in the finished dosage form, they are generally excluded from the final tablet composition and theoretical tablet weight.
Why are multiple API lots sometimes used in a single manufacturing batch?
Manufacturers may use multiple API lots when a single lot is insufficient to complete production, inventory needs to be optimized, or approved stock rotation practices require the use of several qualified lots. All API lots should be approved, within their retest or expiry period, and documented according to GMP requirements.
What factors should be considered when selecting an excipient for tablet formulations?
Excipient selection depends on the intended manufacturing process and desired product performance.
Key selection factors include:
- API compatibility
- Flowability
- Compressibility
- Particle size
- Moisture sensitivity
- Stability
- Dissolution characteristics
- Regulatory acceptance
- Supplier consistency
What information is typically included in a pharmaceutical Master Formula Record (MFR)?
A Master Formula Record generally includes:
- Product name
- Batch size
- Complete list of APIs and excipients
- Approved supplier or manufacturer details
- Theoretical composition
- Manufacturing instructions
- Equipment requirements
- Processing stages
- Environmental conditions
- In-process controls
- Yield calculations
- Packaging instructions
- Quality specifications
It serves as the approved manufacturing document for routine commercial production under GMP.
Why is batch composition accuracy critical for GMP compliance?
Accurate batch composition ensures that every manufactured batch matches the approved formulation and meets predefined quality specifications.
Incorrect material quantities may adversely affect:
- Assay
- Content uniformity
- Dissolution
- Tablet weight
- Stability
- Regulatory compliance
Maintaining accurate batch composition supports data integrity, traceability, reproducibility, successful batch release, and inspection readiness under GMP.
Frequently Asked Questions
What information is required before starting a batch composition calculation?
Begin by entering the optional Product Name, the total Batch Size (number of tablets), and the required output decimal precision. Then add all Active Pharmaceutical Ingredients (APIs) and excipients under their appropriate manufacturing stages. Accurate batch size and formulation details ensure correct material quantities for the entire batch.
How should ingredients be assigned to different formulation stages?
Each ingredient should be entered in the stage where it is actually applicable during manufacturing. Depending on the manufacturing process, materials may be assigned to Intra-granular/Dry Mix, Binder, Blending, Lubrication, or Coating. Organizing ingredients correctly helps produce a stage-wise Bill of Materials (BOM) consistent with the manufacturing process.
Can unused formulation stages be left blank?
Yes. Only stages applicable to your manufacturing process need to be completed. For example, Direct Compression formulations generally do not require Intra-granular or Binder sections, while uncoated tablets do not require entries in the Coating section.
When should an ingredient be selected as an API?
Select API only for Active Pharmaceutical Ingredient(s). This enables assay correction, single-lot or multi-lot calculations, and automatic quantity adjustment.
How many APIs can the calculator handle?
The pharmaceutical calculator can handle both single-API and multi-API formulations. Each API can be entered separately with its respective strength, assay (as-is) value, overage (if applicable), and manufacturing stage. Individual assay corrections are performed for every API, ensuring accurate batch composition while maintaining the desired tablet weight through automatic excipient compensation, when applicable.
When should single-lot API entry be used instead of multiple lots?
Use single-lot mode when the entire batch is manufactured from one API lot. If more than one qualified API lot contributes to the batch, use the Multiple API Lots option so each lot's quantity and assay are individually accounted for.
Which assay value should be entered for an API?
Always enter the Assay (as-is) %. If the Certificate of Analysis reports assay on a dried, anhydrous, or ignited basis, first convert it to the equivalent as-is assay before entering the value to ensure accurate API quantity calculations.
What does the Corrected mg/tab value represent?
The Corrected mg/tab value is the adjusted quantity of API or excipients required per tablet after applying assay correction.
How does the compensating excipient option work?
If API assay correction changes the API quantity, the pharmaceutical calculator automatically adjusts one selected compensating excipient to maintain the target tablet weight. Only one eligible excipient should be selected across the entire formulation.
When should the 'Mark Evaporates' option be used?
Use this option only for water or volatile solvents that evaporate during processing and are not present in the finished tablet. It is applicable only within the Binder and Coating stages.
Should water be entered as an ingredient in the final tablet composition?
Yes, if it is used during granulation or coating. When marked as “evaporates”, it is included for process calculations but excluded from the final tablet composition since it does not remain in the finished product except traces.
Can coating materials be excluded for uncoated tablets?
Yes. The Coating section is required only for coated tablets. For uncoated products, this section may simply be left blank without affecting the remaining calculations.
Can the calculator be used for Direct Compression, Wet Granulation, and Dry Granulation formulations?
Yes. The pharmaceutical calculator supports all three manufacturing methods. Simply complete only the formulation stages applicable to your manufacturing process while leaving unnecessary stages empty.
What information is included in the generated batch composition table?
The results table summarizes the complete Bill of Materials (BOM), including stage-wise ingredient quantities, corrected API amounts, overages, compensation adjustments, and total quantities required for the specified batch size.
Can the calculated batch composition be exported or printed?
Yes. After calculation, the complete Bill of Materials (BOM) can be exported as CSV or Excel, or printed/saved as a PDF for manufacturing records, review, documentation, or technology transfer.
Why should the exported or printed report be reviewed before manufacturing?
Although calculations are automated, users should always verify ingredient entries, API assay values, overages, compensation selections, manufacturing stages, and results. A final review helps ensure the Bill of Materials (BOM) accurately reflects the approved formulation and batch requirements.
Other Pharmaceutical Calculators
Streamline Your Operations with Advanced Pharmaceutical Scaling & Compliance Tools:
Transitioning from laboratory-scale formulation to high-throughput commercial batches requires flawless precision across every mathematical variable. To eliminate calculation bottlenecks, mitigate cross-contamination risks, and expedite technology transfers, explore our suite of interconnected pharmaceutical development and manufacturing calculators.